Tilray Brands, Inc.

NASDAQ:TLRY

Drug Manufacturers - Specialty & Generic

Healthcare
$2.25 -0.84%

-$0.04 today

Market cap
$251.62M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $3.50High $23.20

Volume 5.03M

Average 4.73M

TLRY Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Tilray Brands, Inc.NASDAQ: TLRY

Net Income · Q3 FY2026 · quarter ended Feb 2026

Net income dips below year-ago levels

Q3 FY2026 net income of $25.23M (cash outflow) fell 97.8% year over year, behind the +35.0% change in trailing-twelve-month net income. Sequentially, it fell 58.5% from the prior quarter. Over 3 fiscal years it compounded at +70.9% a year.

Context

  • Net income amounted to 266.3% of revenue in FY2025, up 235.2 pp from a year earlier.
  • Net income grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 7 analysts of -$71.79M (-97.6%) for the fiscal year ending May 2026, a slowdown from the +798.9% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterFeb 2026
-$25.23M-58.5% QoQ
Last fiscal yearMay 2025
-$3B+798.9% YoY
LTMFeb 2026
-$1.83B+35.0% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-97.8%-99.9%-2.2 pp
1 year+798.9%-97.6%-896.5 pp
3-year CAGR+70.9%-80.3%-151.2 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(3B) USD
Year-over-year change
-798.9%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How TLRY compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +35.0% is the highest of 3, against a peer median of -298.7%.
  • Net income amounts to 154.9% of revenue for TLRY, versus a peer median of 10.0%.
TLRY Competitors
Net Income for TLRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TLRYTilray Brands, Inc.LTM Feb 2026$1.83B USD+35.0%+70.9%154.9%
ACBAurora Cannabis Inc.LTM Mar 2026CA$58.58M CAD-507.7%-39.5%18.8%
SNDLSNDL Inc.LTM Mar 2026CA$10.98M CAD-89.7%-65.1%1.2%
GLASGlass House Brands Inc—— ———
Peer median (excluding TLRY) —-298.7%-52.3%10.0%

Competitors are the stored peer set for TLRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Net Income(443.62M)(601.05M)(1.96B)(333.8M)(3B)
Depreciation & Amortization81.9M194.88M175.31M172.93M183.17M
Deferred Income Tax(30.03M)(34.71M)(43.04M)(52.97M)(166.06M)
Stock-Based Compensation00000
Change in Working Capital(61.5M)(115.68M)19.4M(12.09M)(85.85M)
Accounts Receivables(28.39M)(7.36M)5.61M(8.96M)(24.43M)
Inventory(42.6M)(57.67M)(17.42M)(21.23M)(18.61M)
Accounts Payables17.51M(56.29M)27M288.86K(31.48M)
Other Working Capital(8.01M)5.64M4.21M17.81M(11.34M)
Other Non-Cash Items399.26M333.12M1.82B183.82M2.94B
Operating Cash Flow(53.99M)(223.45M)10.65M(42.11M)(129.81M)
Capital Expenditures(46.94M)(42.94M)(28.02M)(39.85M)(45.17M)
Acquisitions (Net)88.4M15.8M(30.19M)(71.01M)(15.49M)
Purchases of Investments00(325.83M)0(3.45M)
Sales of Investments000285.75M0
Other Investing Activities14.2M0000
Investing Cash Flow55.67M(27.14M)(384.04M)174.88M(64.11M)
Debt Repayment56.22M(149.85M)(76.96M)(110.24M)(31.89M)
Common Stock Issued123.99M330.91M174.56M11.74M221.18M
Common Stock Repurchased00(1.6M)00
Dividends Paid00000
Other Financing Activities(30.13M)(19.46M)(1.5M)(3.95M)(6.1M)
Financing Cash Flow150.09M161.6M94.5M(102.45M)183.2M
Effect of Forex Changes321.14M(2.47M)(3M)(748.05K)1.56M
Net Change in Cash472.9M(91.46M)(281.89M)29.58M(9.16M)
Free Cash Flow(100.93M)(266.39M)(17.37M)(81.96M)(174.98M)

Tilray Brands, Inc.

NASDAQ:TLRY

Intrinsic Alpha fair value

Locked

Current Price

$2.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.